Robert Anthony, Ph.D.


Associate Investigator
Center for Immunology and Inflammatory Diseases, Mass General Research Institute
Associate Professor of Medicine
Harvard Medical School
Research Staff
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital
Frisbie Family MGH Research Scholar 2021-2026
Massachusetts General Hospital
PhD Uniform Services University of Health Sciences 2006
allergies; anaphylaxis; cell degranulation; glycoproteins; glycosylation; homeostasis; igg; immunoglobulin fc fragments; immunoglobulin glycosylation; n-acetylneuraminic acid; polysaccharides; receptors ige Antibodies are the preeminent effector proteins of the immune system. The bimodal activity of antibodies allows simultaneous recognition of antigen (by the antigen-binding fragment, Fab) with high affinity, and recruitment and activation of leukocytes through interactions between the constant, crystallizable fragment (Fc) and Fc receptors (FcRs) expressed by innate immune cells. Studies have demonstrated that antibody glycosylation is an important regulator of Fc-FcR interactions. Our laboratory is particularly interested in the role and regulation of IgE and IgG glycosylation in health and disease.
Anthony Lab Publications
robert.anthony@mgh.harvard.edu
6177244245

CNY-Building #149
149 13th Street
307
Charlestown, MA 02129